The Story of Influenza Antivirals: Part 24. Tamiflu and neuropsychiatric adverse events

Why access to regulatory data rather than published articles is essential and why asking pharma if their products cause problems is like asking a fox to guard the henhouse.

A controversial issue with use of Tamiflu was whether it could cause neuropsychiatric adverse events. Prior to the 2009 influenza pandemic, most Tamiflu usage occurred in Japan. Reports of accidental deaths related to abnormal behaviour of Japanese teenagers after ingesting Tamiflu began sporadically occurring in 2004 and hit the mainstream news in many…